March 20, 2026

MajesTEC-3: ‘Unprecedented’ Benefit in Previously Treated Multiple Myeloma

For patients with previously treated multiple myeloma, the greatest risk reduction yet achieved in a phase III clinical trial was reported with the BCMA-directed CD3 T-cell engager teclistamab-cqyv pl...

The ASCO Post

March 20, 2026

Early Findings From First Human Study of In Vivo CAR T in Myeloma

The first-in-human clinical trial of an in vivo CAR T-cell therapy for multiple myeloma has shown encouraging clinical outcomes at an early time point, with a safety profile and ease of administration...

The ASCO Post

March 20, 2026

From Molecules to Meaning

How molecular pathology translates into real patient impact

The Pathologist

March 20, 2026

Expanding the Therapeutic Landscape in Wet Age-related Macular Degeneration

The role of TKIs and sustained‑release delivery

The Ophthalmologist

March 19, 2026

Ophthalmology’s Role in the Opioid Crisis

Retrospective cohort study investigates how ophthalmologists can provide potentially life-saving care to substance use disorder patients

The Ophthalmologist

March 19, 2026

Hoth Applies AI in Development of Candidate for KIT-Driven Cancers

Preclinical results and AI integration support progress toward regulatory submission

The Medicine Maker

March 18, 2026

Medical Oddities: Friends, Family… and Faster Aging?

From gut gas trackers to bat vaccines, relationships and aging, GLP-1 hair shifts, and bug-based delivery—medicine keeps getting creative.

Conexiant

March 18, 2026

New AACR President-Elect and Board Members Announced

The American Association for Cancer Research (AACR) has announced that Robert H. Vonderheide, MD, DPhil, has been named the 2026–2027 AACR President-elect. Dr. Vonderheide is an renowned cancer immuno...

The ASCO Post

March 18, 2026

Targeted NGS Streamlines Myeloproliferative Neoplasm Diagnostics

Kritika Krishnamurthy shares real-world experience on advanced MPN genomic profiling

The Pathologist

March 18, 2026

Liquid Biopsy in Lung and Breast Cancer: Real World Tumour Profiling and Clinical Insights

Liquid biopsy is increasingly being adopted to support tumour profiling across cancer pathways, particularly where tissue is limited or results are needed quickly.

The Pathologist